10 likes | 12 Views
Repurposing of marketed / shelved / pipeline candidates for the treatment of diseases (different from original target indications) has emerged as a viable business strategy. The rising popularity of this approach can further be attributed to various benefits, such as reduced development timelines, decreased investments and relatively higher success rates (considering that the safety profiles of such candidates have already been established).<br> <br>To order this 250 page report, which features 100 figures and 140 tables, please visit this https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html<br><br>Contact Details<br>Gaurav Chaudhary<br> 1 (415) 800 3415<br>gaurav.chaudhary@rootsanalysis.com <br>
E N D